CAS ID: | 366789-02-8 |
Molecular Formula: | C19H18ClN3O5S |
Molecular Weight: | 435.9 g/mol |
Monoisotopic Mass: | 435.0656 g/mol |
Class: | Small Molecule |
Natural Product: | No |
Other Names: | RIVAROXABAN | XARELTO | BAY 59-7939 |
Analysis: | Drug repositioning mechanism analysis |
Reference Record 1
PubMed ID | 26370374 | Target ID | |
Uniprot ID | Name | ||
Model | vitro | Fibrosis Disease | Cardiac fibrosis |
Process I | attenue inflammation | ||
Process II | fibroblasts activation,fibroblasts proliferation,fibroblasts migration | ||
Process III | |||
Mechanism |
Trial Record 1
ClinicalTrial ID | NCT02643212 | Disease | Liver fibrosis |
Phase | Phase 3 | Status | Recruiting |
First Received | December 31, 2015 | Last Verified | April 25, 2018 |
Sponsor | David Garcia Cinca |
PubChem: | 9875401 |
ChEMBL: | CHEMBL198362 |